Cargando…

Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium

Detalles Bibliográficos
Autores principales:	Tricarico, Gerardo, Travagli, Valter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Correspondence and Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181597/ https://www.ncbi.nlm.nih.gov/pubmed/34112484 http://dx.doi.org/10.1016/j.jaip.2021.02.063

Ejemplares similares

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

COVID-19: Precision Medicine and Vascular Endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

COVID-19 fatal outcomes: Role of the endothelial glycocalyx in both cell adhesion and migration
por: Tricarico, Gerardo, et al.
Publicado: (2021)

The Relationship between Ozone and Human Blood in the Course of a Well-Controlled, Mild, and Transitory Oxidative Eustress
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures
por: Javad Mortazavi, Seyed Mohammad, et al.
Publicado: (2021)

Reply to “Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures”
por: Crucian, Brian E., et al.
Publicado: (2021)

Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022)

Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)

Does asthma affect outcomes of patients with COVID-19 infections?
por: Kalemci, Serdar, et al.
Publicado: (2021)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

Mortality-related immune features and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

PEG skin testing for COVID-19 vaccine allergy
por: Stone, Bryan D.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

COVID-19 “infodemics” and asthmatic children: The return to school challenge
por: Boechat, José Laerte, et al.
Publicado: (2021)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
por: Mesli, Farah, et al.
Publicado: (2021)

Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
por: Drake, Matthew G., et al.
Publicado: (2021)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021)

A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter
por: Maeda, Yohei, et al.
Publicado: (2022)

Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022)

Reply to Scarpati, G.; Piazza, O. Comment on “Guerrero-Romero et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients 2022, 14, 1686”
por: Guerrero-Romero, Fernando, et al.
Publicado: (2022)

Impact of more variations on in‐hospital mortality among patients with confirmed COVID‐19
por: Jia, Na, et al.
Publicado: (2022)

Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection—reply
por: Mendez-Echevarria, Ana, et al.
Publicado: (2021)

Reply to: “Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020, 12, 2757”
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Authors’ reply: the biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Bayramoğlu, Elvan, et al.
Publicado: (2021)

SARS-CoV-2 reinfection or persistence among immunodeficient patients
por: Özdemir, Öner
Publicado: (2023)

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

Reply to Comments: Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI(0)) in Clinical Practice
por: Spronck, Bart, et al.
Publicado: (2020)

Reply to Comments on the Study “The Sensitivity, Specificity and Accuracy of Warning Signs in Predicting Severe Dengue, the Severe Dengue Prevalence and its Associated Factors”
por: Ahmad, Mohd Hanief, et al.
Publicado: (2019)

Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on “Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57”
por: Luchian, Maria-Luiza, et al.
Publicado: (2022)

Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”
por: Grant, William B., et al.
Publicado: (2020)

Reply to Ayuso García et al. Health Perception among Female COVID-19 Patients. Comment on “Fernández-de-las-Peñas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022, 11, 413”
por: Fernández-de-las-Peñas, César, et al.
Publicado: (2022)

A Flexible Lockdown by Integrating Public Health and Economic Reactivation to Response the Crisis of COVID-19: Responses to Comments by Alvaro J Idrovo on “An Examination on the Transmission of COVID-19 and the Effect of Response Strategies: A Comparative Analysis”
por: Chen, Yi-Tui, et al.
Publicado: (2020)

Reply to “Letter to the Editor for the Review Paper: The association between blood pressure variability with dementia and cognitive function: A systematic review and meta‐analysis”
por: Chiu, Tzu‐Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_97ubijq85gd663qgj1vbnkfqd4